tiprankstipranks
Trending News
More News >
Traws Pharma (TRAW)
NASDAQ:TRAW
US Market

Traws Pharma (TRAW) Income Statement

Compare
1,857 Followers

Traws Pharma Income Statement

Last quarter (Q1 2025), Traws Pharma's total revenue was $57.00K, an increase of 1.79% from the same quarter last year. In Q1, Traws Pharma's net income was $21.49M. See Traws Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 226.00K$ 226.00K$ 226.00K$ 226.00K$ 231.00K
Gross Profit
$ 214.00K$ 210.00K$ 212.00K$ 212.00K$ 231.00K
Operating Expenses
$ 142.60M$ 20.51M$ 19.85M$ 16.72M$ 25.22M
Depreciation and Amortization
$ 12.00K$ 16.00K$ 14.00K$ 14.00K$ 13.00K
EBITDA
$ -24.90M$ -20.28M$ -19.61M$ -16.48M$ -24.98M
Operating Income
$ -142.37M$ -20.30M$ -19.63M$ -16.50M$ -24.99M
Other Income/Expenses
$ -24.15M$ 1.35M$ 663.00K$ 333.00K$ -160.00K
Pretax Income
$ -166.52M$ -18.95M$ -18.96M$ -16.16M$ -25.15M
Net Income
$ -166.52M$ -18.95M$ -18.96M$ -16.16M$ -25.16M
Per Share Metrics
Basic EPS
$ -6.58$ -0.90$ -0.91$ -0.96$ -2.17
Diluted EPS
$ -6.58$ -0.90$ -0.91$ -0.96$ -2.17
Weighted Average Shares Outstanding
25.31M 20.99M 20.91M 16.83M 11.60M
Weighted Average Shares Outstanding (Diluted)
25.31M 21.00M 20.91M 16.83M 11.60M
Currency in USD

Traws Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis